For many years, Fragile X Syndrome has affected millions of people worldwide. This is the condition that is thought to be the most common genetic cause of autism.
Recently, an affluent family has been donating funds to a drug company that is focused on treating this condition that is the root cause of most cases of autism across the globe. This story is the central focus of an article in Chemical and Engineering News weekly magazine.
Unfortunately, their concerns were focused on drugs such as Viagra and Cialis as opposed to drugs that would greatly affect the overall well being and lives of millions across the world.
The article states, further that until recently there was very minimal interest in developing autism drugs from big pharmaceutical drugs. Unfortunately, their concerns were focused on drugs such as Viagra and Cialis as opposed to drugs that would greatly affect the overall well being and lives of millions across the world. Moving forward, a small drug company in Cambridge, Massachusetts named Seaside Therapeutics was the only company trying to develop drugs for autism and the Fragile X Syndrome. The syndrome affects about 1 in 4,000 males and 1 in 6,000 females and is the result of a single mutated gene. The symptoms of this condition vary from hearing impairment to mental retardation.
As the number of autism cases worldwide continues to grow at an increased rate since the 1980’s, companies like Seaside continue to press forward to fight a weapon to combat this condition. Clinical trials of two of their new drugs show immense promise and may soon be able to help so many of the people worldwide who need a helping hand in this difficult fight.